An altered peptide ligand specifically inhibits Th2 cytokine synthesis by abrogating TCR signaling

Journal of Immunology

Volumn 162, Issue 3, 1999, Pages 1836-1842

  Faith, Alexander ^a   Akdis, Cezmi A ^a   Akdis, Mübeccel ^a   Joss, Andrea ^a   Wymann, Daniel ^a   Blaser, Kurt ^a  

^a SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; LIGAND; PEPTIDE; PHOSPHOLIPASE A2; PROTEIN TYROSINE KINASE; T LYMPHOCYTE RECEPTOR; TYROSINE;

ALLERGIC REACTION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE;

CLONAL ANERGY; CLONE CELLS; CYTOKINES; HLA-DP ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-4; KINETICS; LIGANDS; LYMPHOCYTE ACTIVATION; PEPTIDES; PHOSPHOLIPASES A; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; TH2 CELLS; TYROSINE; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 0033083289     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Romagnani, S. 1994. Lymphokine production by human T cells in disease states. Annu. Rev Immunol. 12:227.
2. Zurawski, G., and J. E. de Vries. 1994. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 15:19.
3. Walker, C., J. C. Virchow, P. L. B. Bruijnzeel, and K. Blaser. 1991. T cell subsets and their soluble products regulate eosinophilia in allergic and nunallergic asthma. J. Immunol. 146:1829.
4. Hoyne, G. F., Kristensen, N. M., Yssel Y., and Lamb J. R. 1995. Peptide modulation of allergen-specific immune responses. Curr. Opin Immunol. 7:757.
5. Jutel, M., W. J. Pichler, D. Skrbic, A. Urwyler, C. Dahinden, and U. R. Müller. 1995. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen stimulated T cell cultures. J. Immunol. 154:4187.
6. Secrist, H., C. J. Chelen, Y. Wen, J. D. Marshall, and D. T. Umetsu. 1993. Allergen immunotherapy decreases IL-4 production in CD4 cells from allergic individuals. J. Exp. Med. 178:2123.
7. Akdis, C. A., M. Akdis, T. Blesken, D. Wymann, S. S. Alkan, U. Muller, and K. Blaser. 1996. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J. Clin. Invest. 98:1676.
8. Norman, P. S., J. L. Ohmann, A. A. Long, P. S. Cretricos, M. A. Gefter, Z. Shaked, R. A. Wood, P. A. Eggleston, K. B. Hafner, L. M. Lichtenstein, N. H. Jones, and C. F. Nocodemus. 1996. Treatment of cat allergy with T cell reactive peptides. Am. J. Respir. Crit. Care Med. 154:1621.
9. 2 induces specific T cell anergy in patients allergic to bee venom. J. Allergy Clin. Immunol. 101:747.
10. lck and ZAP-70 tyrosine kinase activities. J. Immunol. 159:53.
11. Fasler, S., G. Aversa, A. Terr, K. Thestrup-Pedersen, J. E. de Vries, and H. Yssel. 1995. Peptide-induced anergy in allergen-specific human Th2 cells results in lack of cytokine production and B cell help for IgE synthesis. J. Immunol. 155:4199.
12. Mueller, D. L., M. K. Jenkins, and R. H. Schwartz. 1989. Clonal expansion versus functional clonal inactivation. Annu. Rev. Immunol. 7:445.
13. Carballido, J. M., A. Faith, N. Carballido-Perrig, and K. Blaser. 1997. The intensity of T cell receptor engagement determines the cytokine pattern of human allergen-specific T helper cells. Eur. J. Immunol. 27:515.
14. + T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J. Exp. Med. 181:1081.
15. Sloan-Lancaster, J., and P. M. Allen. 1996. Altered peptide ligand-induced partial T cell activation:molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14:1.
16. Windhagen, A., C. Scholz, P. Hölsberg, H. Fukaura, A. Sette, and D. A. Hafler. 1995. Modulation of cytokine pattern of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 2:373.
17. + T cells. J. Immunol 157:2160.
18. Evavold, B. D., J. Sloan-Lancasier, B. L. Hsui, and P. M. Allen. 1991. Separation of Th1 clone cytolysis from proliferation and lymphokine production using analog peptides. J. Immunol. 150:3131.
19. - T cells by antigenic peptides altered for TCR binding. J. Immunol. 158:4237.
20. Sloane-Lancaster, J., B. D. Evavold, and P. M. Allen. 1994. Th2 cell clonal anergy as a consequence of partial activation. J. Exp. Med. 180:1195.
21. Tsitoura D. C., W. Holter, A. Cerwenka, C. M. Gelder, and J. R. Lamb. 1996. Induction of anergy in human T helper O cells by stimulation with altered T cell antigen receptor ligands. J. Immunol. 156:2801.
22. Matsuoka, T., H. Kohrogi, M. Ando, Y. Nishimura, and S. Matsushita. 1996. Altered TCR ligands affect antigen-presenting cell responses. J. Immunol 157: 4837.
23. Pfeiffer C., J. Stein, S. Southwood, H. Ketelaar, A. Sette, and K. Bottomly. 1995. Altered peptide ligands can control T lymphocyte differentiation in vivo. J. Exp. Med. 181:1569.
24. Kumar, V., V. Bhardwaj, L. Soares, J. Alexander, A. Sette, and E. Sercarz. 1995. Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of IL-4/5 or IFN-γ by T cells. Proc. Natl. Acad. Sci. USA 92:9510.
25. Brocke, S., K. Gijbels, M. Allegretta, I. Ferber, C. Piercey, T. Blankenstein, R. Martin, U. Utz, N. Karin, D. Mitchell et al. 1996. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379: 343.
26. 2. Biochim. Biophys. Acta 1165:201.
27. 2, J. Immunol. 150: 3582.
28. 2-specific T cell clones from human allergic and non-allergic individuals: cytokine patterns change in response to the antigen concentration. Eur. J. Immunol. 22:1357.
29. Santamaria Babi, L. F., L. F. Picker, M. T. Perez Soler, K. Drzimalla, P. Flohr, K. Blaser, and C. Hauser. 1995. Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen. J. Exp. Med 181:1935.
30. Gillis, S., M. M. Ferm, W. Ou, and K. A. Smith. 1978. T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120:2027.
31. Busch, R., and J. B. Rothbard. 1990. Detection of peptide-MHC class II complexes on the surface of intact cells. J. Immunol. Methods 134:1.
32. Evavold, B. D., and P. M. Allen. 1991. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 252:1308.
33. 2 in vitro. J. Allergy Clin. Immunol. 93:758.
34. + T cells, analyzed at the single cell level. J. Exp. Med. 184:473.
35. Stern, L. J., J. H. Brown, T. S. Jardetzky, J. C. Gorga, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368: 215.
36. Fremont, D. H., W. A. Hendrickson, P. Marrack, and J. Kappler. 1996. Structures of an MHC class II molecule with covalently bound single peptides. Science 272:1001.
37. Vergelli, M., B. Hemmer, U. Utz, A. Vogt, M. Kalbus, L. Tranquill, P. Conlon, N. Ling, L. Steinman, H. F. McFarland, and R. Martin. 1996. Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87-99). Eur. J. Immunol. 26:2624.
38. Lamb, J. R., J. A. Higgins, C. Hetzel, J. D. Hayball, R. A. Lake, and R. E. O'Hehir. 1995. The effects of changes at peptide residues contacting MHC class II T cell receptor on antigen recognition and human Th0 effector function. Immunology 85:447.
39. Viola, A., and A. Lanzavecchia. 1996. T cell activation determined by TCR number and tuneable thresholds. Science 273:104.
40. King, C. L., J. Xianli, C. H. June, R. Abe, and K. P. Lee. 1996. CD28-deficient mice generate an impaired Th2 response to Schistosoma mansoni infection. Eur. J. Immunol. 26:2448.
41. Cause, W. C., M. J. Halvorson, P. Lu, R. Greenwald, P. Linsley, J. F. Urban, and F. D. Finkelman. 1997. The function of costimulatory molecules and the development of IL-4 producing T cells. Immunul. Today 18:115.
42. De Silva, D. R., K. B. Urdahl, and M. K. Jenkins. 1991. Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J. Immunol. 147:3261.
43. + T cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature 389:737.
44. Akdis, C. A., T. Blesken, M. Akdis, B. Wüthrich, and K. Blaser. 1998. The role of IL-10 in specific immunotherapy. J. Clin. Invest. 102:98.
45. lck. Nature 350:62.
46. fyn regulate CD28 recruitment of phosphotidylinositol 3 kinase, growth factor receptor bound grb-2 and T cell specific protein tyrosine kinase 1TK: implications for co-stimulation. Proc. Natl. Acad. Sci. USA 92:8891.
47. 4 antibodies in vitro requires allergen-specific and non-specific activation of T and B cells. J. Allergy Clin. Immunol. 99:345.